Clostridium difficile infection in patients with neutropenia.
about
Clostridium difficile Infection in Children: Current State and Unanswered QuestionsAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage StudyHospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcomeHematologic diseases: high risk of Clostridium difficile associated diarrheaPoorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitalsClostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes.Neutropenic enterocolitis in adults: systematic analysis of evidence quality.Antibiotic-associated diarrhoea.Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients.Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantationLethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature.Nosocomial diarrhea: a review of pathophysiology, etiology, and treatment strategies.Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).The prevention and management of infections due to multidrug resistant organisms in haematology patientsManagement of Acute Myeloid Leukemia in the Intensive Care Setting.The epidemiology of Clostridium difficile infection in patients with cancer.Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis.Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology.Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation.Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia.Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease.Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients.Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system.Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Treatment of Clostridium difficile infection.A Retrospective Study Analyzing the Appropriateness of Initial Treatment of Clostridium difficile in Patients with Active Malignancy.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Risk Factors for Clostridium difficile Infection in a Hepatology Ward
P2860
Q27016320-1E67A55B-EA1E-4314-BEAA-5806F1348750Q30238945-77E053E6-2BED-4E5D-A56E-08DEC1772BCAQ31108764-ABD71615-A705-40A6-8341-46F028F145DCQ33285304-7DDBB849-A335-4774-A000-7065AAD59CFAQ33718326-0DD0D18D-301C-4560-9F72-75363BB74365Q33827614-08FCB3A0-CC4D-4C80-BAC6-A0AD139DA06AQ34461701-9C8288B3-D7D7-4897-9E18-4AE571114D3DQ34624447-A256F54C-ADD5-48CE-95BB-1AED3D797CBEQ35596937-C431FCEC-CAE3-4038-A028-86FF19307497Q36077707-97635F2C-E6BE-444E-B31B-FE62726C1937Q36157228-AE2F8A13-C04E-4045-AE45-3162C7329C9AQ36446885-7F0EFE97-D0A4-4BA8-9BA3-DF36AF37916CQ37166564-64D6A61F-FBBA-4B96-8B0F-C99B0CC06D8BQ37287190-03C4FAE4-90FF-4A88-8FE8-B0EA80ED2F82Q37386066-FDE74201-DA76-4521-BA06-BEC5DEF8B6BEQ37779742-B159E3FE-AB8F-412A-980D-687D7E9A95E7Q37992488-C552DC92-B094-4DC2-A0FD-536BFBC43BD2Q38080794-FD8F350F-2847-41CB-9828-C2559E8106EAQ38171538-366F2EEE-0A2B-40BA-B17E-A28BE0682C7BQ38206394-DBBDB547-DE27-4BF0-BE6A-013CCD970537Q38823326-299FAF85-E906-42C9-92A8-7F172B4A4883Q39762020-883B1CA2-CC78-4D7C-A16B-9A27A0B5083CQ40250713-E0D752D8-711B-44C0-9C18-D6BB3B04CE5DQ40325692-06F70E38-1E36-406B-A49D-C8509A44CAC5Q40583864-A0ADCA7D-B7F1-492E-A72E-60BFDBDA9F41Q40870178-6B74BBD5-6AD7-466C-9B1C-7E63D85F1C7DQ40873565-D06894E0-736C-431D-866E-94B4FE35E8B1Q41194710-3C3E0B3F-D3D8-4105-A46A-6BAC693E5C80Q41410906-D1471EA5-0F0D-4D78-A909-880A6BF293AAQ42225665-50C74DAC-2497-48DF-9A6F-776608883D2FQ42702938-41CFCB03-D661-412A-B0F6-B9DD5F8F0EB3Q43100736-75382D94-0ED1-4A8C-9B92-C38FD18C8C5BQ44356314-F8101735-374A-41E0-BB3C-7BC12870D7E2Q44865750-E786C021-B761-429D-83A9-2C71F3E47B2AQ47441605-E8CC4AB2-DF98-4E4A-8C56-1CA50504B023Q49195473-86D88E2F-1027-4BF1-AB37-24C36570FC53Q51894323-E445517D-2285-4F74-BCDE-4A92711E27E8Q55476382-3299DF28-4104-42DD-A6C3-34DDEB1D4806Q56225357-F08CEB36-CC91-42D4-952C-2890C4BA1B6BQ58034464-0E8CCCAC-2129-4C88-AC30-D337D7339C4A
P2860
Clostridium difficile infection in patients with neutropenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clostridium difficile infection in patients with neutropenia.
@ast
Clostridium difficile infection in patients with neutropenia.
@en
Clostridium difficile infection in patients with neutropenia.
@nl
type
label
Clostridium difficile infection in patients with neutropenia.
@ast
Clostridium difficile infection in patients with neutropenia.
@en
Clostridium difficile infection in patients with neutropenia.
@nl
prefLabel
Clostridium difficile infection in patients with neutropenia.
@ast
Clostridium difficile infection in patients with neutropenia.
@en
Clostridium difficile infection in patients with neutropenia.
@nl
P2093
P2860
P356
P1476
Clostridium difficile infection in patients with neutropenia.
@en
P2093
Glasmacher A
Gorschlüter M
Marklein G
Sauerbruch T
Schakowski F
Schmidt-Wolf IG
P2860
P304
P356
10.1086/322616
P407
P577
2001-08-10T00:00:00Z